James C. Fitzpatrick

James C. Fitzpatrick is Co-Chair of Hughes Hubbard’s Product Liability practice group and a member of the firm’s Litigation department. His practice focuses on domestic and international pharmaceutical and product liability litigation as well as other types of complex commercial litigation.

Jim’s practice also includes the development and presentation of scientific issues at trial, in the media, and as part of Congressional and Department of Justice investigations. He has litigated securities and Employee Retirement Income Security Act matters in the pharmaceutical area, as well as product liability trials in the US and around the world. Chambers USA, The Legal 500, The International Who's Who of Product Liability Defence Lawyers, and a number of other publications have consistently recognized Jim as a top product liability lawyer. In the 2021 International Who’s Who of Product Liability Defence Lawyers, Jim was praised for doing “a great job coordinating global strategy for his clients’ best interests” and sits “among the leading product liability specialists in New York.” Jim was also recognized as a “Thought Leader: Global Elite” in the 2022 International Who’s Who of Life Science – Product Liability Lawyers.

• Representation of Merck & Co. Inc. and Merck Animal Health in multiple product liability and commercial litigation matters
• Representation of Organon & Co., in multiple product liability litigations
• Representation of Pfizer in the defense of product liability matters involving Lipitor
• Representation of the trustee of Lehman Brothers Inc. in multiple litigations including arguments in the Bankruptcy Court, District Court, and Second Circuit Court of Appeals 
• Representation of Lorillard Tobacco Co. in the defense of smoking-and-health litigation 
• Representation of Broadcast Music Inc. (BMI) in multiple litigations involving music license fees